Comparison of algorithms that detect drug side effects using electronic healthcare databases

Soft Computing

Volumn 17, Issue 12, 2013, Pages 2381-2397

  Reps, Jenna Marie ^a   Garibaldi, Jonathan M ^a   Aickelin, Uwe ^a   Soria, Daniele ^a   Gibson, Jack ^b   Hubbard, Richard ^b  

^a Intelligent Modelling and Analysis   (United Kingdom)

^b NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

Adverse drug event; Disproportionality methods; Electronic healthcare database; HUNT; Longitudinal observational database; MUTARA; Temporal pattern discovery

Indexed keywords

ADVERSE DRUG EVENT; DISPROPORTIONALITY METHODS; ELECTRONIC HEALTHCARE; HUNT; MUTARA; TEMPORAL PATTERN DISCOVERY;

ALGORITHMS; DRUG INTERACTIONS; HEALTH CARE; SIGNAL DETECTION;

DATABASE SYSTEMS;

EID: 84888036811     PISSN: 14327643     EISSN: 14337479     Source Type: Journal    
DOI: 10.1007/s00500-013-1097-4     Document Type: Article

References (28)

1. Almenoff J, Tonning JM, Gould AL et al (2005) Perspectives on the use of data mining in pharmacovigilance. Drug Saf 28(11): 981-1007.
2. Alvarez-Requejo A, Carvajal A, Begaud B et al (1998) Under-reporting of adverse drug reactions-estimate based on a spontaneous reporting scheme and a sentinel system. Eur J Clin Pharmacol 54(6): 483-488.
3. Bate A, Lindquist M, Edwards IR et al (1998) A bayesian neural network method for adverse drug reaction signal generation. Eur J Clin Pharmacol 54: 315-321.
4. Behrman RE, Benner JS, Brown JS et al (2011) Developing the sentinel system-a national resource for evidence development. N Engl J Med 364: 498-499.
5. Brown JS, Kulldorff M, Chan A et al (2007) Early detection of adverse drug events within population-based health networks: application of sequential testing methods. Pharmacoepidemiol Drug Saf 16: 1275-1284.
6. Coloma PM, Schuemie MJ, Trifiro G et al (2011) Combining electronic healthcare databases in europe to allow for large-scale drug safety monitoring: the eu-adr project. Pharmacoepidemiol Drug Saf 20: 1-11.
7. Curtis JR, Cheng H, Delzell E et al (2008) Adaptation of bayesian data mining algorithms to longitudinal claims data: coxib safety as an example. Med Care 46: 969-975.
8. DuMouchel W (1999) Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting systemt. Am Stat 53(3): 177-190.
9. Evans SJW, Waller PC, Davis S (2001) Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf 10(6): 483-486.
10. INPS (2011) A Cegedim company: welcome to inps. http://www. inps4. co. uk/. Accessed 25 Jan 2012.
11. Jin H, Chen J, Kelman C et al (2006) Mining unexpected associations for signalling potential adverse drug reactions from administrative health databases. In: PAKDD, pp 867-876.
12. Jin HW, Chen J, He H et al (2010) Signaling potential adverse drug reactions from administrative health databases. IEEE Trans Knowl Data Eng 22(6): 839-853.
13. Joint Formulary Committee (2011) British National Formulary, 62nd edn. BMJ Group and Pharmaceutical Press, London.
14. Lewis JD, Bilker WB, Weinstein RB, Strom BL (2005) The relationship between time since registration and measured incidence rates in the general practice research database. Pharmacoepidemiol Drug Saf 14(7): 443-451.
15. Noren GN, Hopstadius J, Bate A et al (2010) Temporal pattern discovery in longitudinal electronic patients records. Data Min Knowl Disc 20: 361-387.
16. Piromohamed M, James S, Meakin S et al (2004) Adverse drug reactions as cause of admission to hospital: prospective analysis of 18820 patients. Br Med J 329: 15-19.
17. Rosenberg L, Coogan P, Palmer J (2007) Case-control surveillance. In: strom bl (ed) Pharmacoepidemiology, 4th edn. Wiley, Chichester.
18. Ryan PB, Powell G, Pattishall E, Beach K (2009) Performance of screening multiple observational databases for active drug safety surveillance. International Society of Pharmacoepidermiology, Providence, RI.
19. Ryan PB, Madigan D, Stang PE, Overhage JM, Racoosin JA, Hartzema AG (2012) Empirical assessment of methods for risk identification in healthcare data: results from the experiments of the observational medical outcomes partnership. Stat Med 31: 4401-4415.
20. Schuemie MJ, Coloma PM, Straatman H, Herings RMC, Trifir G, Matthews JN, Prieto-Merino D, Molokhia M, Gini LPR, Innocent F, Mazzaglia G, Picelli G, Scotti L, van der Lei J, Sturkenboom MCJM (2012) Using electronic health care records for drug safety signal detection: A comparative evaluation of statistical methods. Med Care 50(10): 890-897.
21. Shephard E, Stapley S, Hamilton W (2011) The use of electronic databases in primary care research. Fam Pract 28(4): 352-354. doi: 10. 1093/fampra/cmr039.
22. Story NL (1974) Sexual dysfunction resulting from drug side effects. J Sex Res 10(2): 132-149.
23. van Puijenbroek EP, Bate A, Leufkens HGM et al (2002) A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol Drug Saf 11(1): 3-10.
24. WHO Collaborating Centre for Drug Statistics Methodology: ATC classification index with DDDs, 2013. Oslo (2012).
25. Wilke RA, Xu H, Denny JC et al (2001) The emerging role of electronic medical records in pharmacogenomics. Int J Clin Pharmacol Ther 89(3): 379-386.
26. World Health Organization: International Statistical Classification of Diseases and Related Health Problems (The) ICD-10. 2010 Edition. Nonserial Publications (2011).
27. Zhou X, Murugesan S, Bhullar H, Liu Q, Cai B, Wentworth C, Bate A (2013) An evaluation of the thin database in the omop common data model for active drug safety surveillance. Drug Saf 36: 119-134.
28. Zorych I, Madigan D, Ryan P et al (2011) Disproportionality methods for pharmacovigilance in longitudinal observational databases. Stat Methods Med Res 1-18.